Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company develops clinical asset comprising Varegacestat, a gamma secretase inhibitor...
42 insider purchases on record · latest filing 2026-06-09.
Insiders have also filed 29 sale transactions at IMNM.